Goodbody Health Limited (GDBYF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.85 Million | -2.34 Million | -2.61 Million | -76.27 Thousand | -8202.07 | -33.65 Thousand |
| Net Income | -2.24 Million | -4.78 Million | -3.79 Million | -348.81 Thousand | -175.46 Thousand | -40.4 Thousand |
| Depreciation & Amortization | 1.04 Million | 471.38 Thousand | 259.53 Thousand | - | - | - |
| Deferred income taxes | 1.43 Million | 381.98 Thousand | 238.28 Thousand | - | - | - |
| Stock-based compensation | 276.61 Thousand | 1.1 Million | 729.65 Thousand | 108.8 Thousand | - | - |
| Change in working capital | 1.41 Million | 382.42 Thousand | -54.25 Thousand | -9188.82 | 5931.79 | 9219.96 |
| Other non-cash items | -67.14 Thousand | 97.2 Thousand | 11.4 Thousand | 172.92 Thousand | 161.32 Thousand | -2475.77 |
| Investing Cash Flow | -122.22 Thousand | 2.41 Million | -493.13 Thousand | -8229.91 | - | -37.66 Thousand |
| Investments in PPE | -253.64 Thousand | -245.89 Thousand | -525.35 Thousand | -8229.91 | - | - |
| Acquisitions | - | 2.47 Million | - | - | - | - |
| Investment purchases | - | 35 Thousand | - | - | - | - |
| Sales/Maturities of investments | - | 42.62 Thousand | 27.21 Thousand | - | - | - |
| Other Investing Activities | 131.42 Thousand | 104.93 Thousand | 5000.00 | - | - | -37.66 Thousand |
| Financing Cash Flow | 2.46 Million | -184.12 Thousand | 1.35 Million | 141.16 Thousand | 8589.10 | 724.25 |
| Debt repayment | -202.16 Thousand | -184.12 Thousand | -94.65 Thousand | -54.55 Thousand | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 2.66 Million | - | 1.48 Million | 145.73 Thousand | - | - |
| Other Financing Activities | - | - | -33.73 Thousand | 49.98 Thousand | - | - |
| Accounts receivables | -165.65 Thousand | 86.64 Thousand | -116.1 Thousand | - | - | - |
| Accounts payables | 1.25 Million | 97.44 Thousand | 157.6 Thousand | - | - | - |
| Inventory | -286.41 Thousand | -199.44 Thousand | -95.75 Thousand | - | - | - |
| Other working capital | 610.56 Thousand | 397.78 Thousand | - | - | - | - |
| Cash at beginning of period | 1.87 Million | 1.99 Million | 3.74 Million | 360.54 | -10.38 | 70.58 Thousand |
| Cash at end of period | 6.06 Million | 1.87 Million | 1.99 Million | 57.01 Thousand | 376.65 | -9.85 |
| Capital Expenditure | -253.64 Thousand | -245.89 Thousand | -525.35 Thousand | -8229.91 | - | - |
| Effect of forex changes on cash | - | - | - | 0.07 | - | - |
| Net cash flow / Change in cash | 4.19 Million | -119.93 Thousand | -1.75 Million | 56.65 Thousand | 387.03 | -70.59 Thousand |
| Free Cash Flow | 1.6 Million | -2.59 Million | -3.13 Million | -84.5 Thousand | -8202.07 | -33.65 Thousand |
| Breakdown | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 FY | 2021 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.26 Million | -1.14 Million | -266.03 Thousand | -978.74 Thousand | -2.24 Million | 1857.00 |
| Depreciation & Amortization | 141.36 Thousand | 136.76 Thousand | 128.38 Thousand | 255.64 Thousand | 1.04 Million | 257.79 Thousand |
| Deferred income taxes | 276.56 Thousand | 250.34 Thousand | 468.2 Thousand | 1.01 Million | 1.43 Million | 169.54 Thousand |
| Stock-based compensation | 3156.00 | 3274.00 | 12.93 Thousand | 205.99 Thousand | 276.61 Thousand | 14.98 Thousand |
| Change in working capital | 95.5 Thousand | -1.24 Million | -356.71 Thousand | 1.66 Million | 1.41 Million | 50.4 Thousand |
| Other non-cash items | -2429.00 | 1836.00 | 470.48 Thousand | 934.06 Thousand | -67.14 Thousand | 172.71 Thousand |
| Investing Cash Flow | 173.11 Thousand | -162.83 Thousand | -71.72 Thousand | 35.41 Thousand | -122.22 Thousand | -37.19 Thousand |
| Investments in PPE | -41 Thousand | -188.63 Thousand | -80.4 Thousand | -95.35 Thousand | -253.64 Thousand | -37.19 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 214.12 Thousand | 25.8 Thousand | 8687.00 | 123.23 Thousand | 131.42 Thousand | -3953.00 |
| Financing Cash Flow | -108.45 Thousand | -43.67 Thousand | -47.58 Thousand | -77.95 Thousand | 2.46 Million | -51.36 Thousand |
| Debt repayment | -108.45 Thousand | -43.67 Thousand | -47.58 Thousand | -56.28 Thousand | -202.16 Thousand | -52.49 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | -185.2 Thousand | 2.66 Million | 1196.00 |
| Other Financing Activities | - | - | - | 163.54 Thousand | - | -69.00 |
| Accounts receivables | 212.01 Thousand | 19.67 Thousand | -29.18 Thousand | 2102.00 | -165.65 Thousand | 14.63 Thousand |
| Accounts payables | -307.33 Thousand | -1.28 Million | 194.31 Thousand | 703.41 Thousand | 1.25 Million | -55.9 Thousand |
| Inventory | 105.86 Thousand | 19.75 Thousand | -12.83 Thousand | 80.95 Thousand | -286.41 Thousand | -39.05 Thousand |
| Other working capital | 84.95 Thousand | 5682.00 | -1.01 Million | 1.75 Million | 610.56 Thousand | 261.45 Thousand |
| Cash at beginning of period | 3.73 Million | 5.93 Million | 6.06 Million | 4.02 Million | 1.87 Million | 3.61 Million |
| Cash at end of period | 3.04 Million | 3.73 Million | 5.93 Million | 6.06 Million | 6.06 Million | 4.02 Million |
| Capital Expenditure | -41 Thousand | -188.63 Thousand | -80.4 Thousand | -95.35 Thousand | -253.64 Thousand | -37.19 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -687.42 Thousand | -2.2 Million | -130.23 Thousand | 2.04 Million | 4.19 Million | 409.19 Thousand |
| Free Cash Flow | -793.09 Thousand | -2.18 Million | -91.34 Thousand | 1.98 Million | 1.6 Million | 460.56 Thousand |
8521
0QM5
QFE
HBLN
WCAT
603037